Associations of insulin resistance and beta-cell function with abnormal lipid profile in newly diagnosed diabetes

被引:2
|
作者
Tang Xiaohan [1 ]
Yan Xiang [1 ]
Zhou Houde [1 ]
Huang Gan [1 ]
Niu Xiaohong [10 ]
Jiang Hongwei [10 ]
Su Heng [10 ]
Yang Xilin [21 ]
Li Xia [1 ]
Zhou Zhiguang [1 ]
机构
[1] Department of Endocrinology
[2] Heji Hospital Affiliated to Changzhi Medical College  12. Changzhi  13. Shanxi 046000  1
[3] Department of Metabolism and Endocrinology
[4] Department of Epidemiology and Biostatistics
[5] School of Public Health  23. Tianjin Medical University  24. Tianjin 300070
[6] National Clinical Research Center for Metabolic Diseases  3. Key Laboratory of Diabetes Immunology (Central South University)  4. Ministry of Ed
基金
国家重点研发计划;
关键词
Beta-cell function; Dyslipidemia; Insulin resistance; Type; 1; diabetes; 2;
D O I
暂无
中图分类号
R587.1 [糖尿病];
学科分类号
1002 ; 100201 ;
摘要
Background: Abnormal lipids are strong predictors of cardiovascular disease in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). However, the potential associations of insulin resistance (IR) and beta-cell function (BCF) with abnormal lipids in newly diagnosed T1DM or T2DM patients are not fully understood.Methods: A cross-sectional survey of 15,928 participants was conducted. Homeostasis model assessment and postprandial C-peptide levels were used to estimate IR and BCF. A restricted cubic spline (RCS) nested in binary logistic regression was used to examine the associations of IR and BCF with abnormal lipids.Results: High triglyceride (TG), low high-density lipoprotein cholesterol, and high low-density lipoprotein cholesterol (LDL-C) accounted for 49.7%, 47.8%, and 59.2% of the participants, respectively. In multivariable analysis, high IR was associated with an increased risk of high TGs (P for trend <0.001) in T1DM and is associated with an elevated risk of high TG and low HDL-C (allP for trend <0.01) in T2DM. Low BCF was not associated with risks of dyslipidemia in patients with T1DM or T2DM after adjustment for potential confounders.Conclusion: High IR had different associations with the risk of dyslipidemia in newly diagnosed T1DM and T2DM patients, suggesting that early treatment that improves IR may benefit abnormal lipid metabolism.
引用
收藏
相关论文
共 50 条
  • [21] Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
    Lachin, John M.
    McGee, Paula L.
    Greenbaum, Carla J.
    Palmer, Jerry
    Pescovitz, Mark D.
    Gottlieb, Peter
    Skyler, Jay
    PLOS ONE, 2011, 6 (11):
  • [22] Insulin Resistance, but Not Impaired Beta-Cell Function, at Type 2 Diabetes Diagnosis Is Associated with Mortality
    Otten, Julia
    Tavelin, Bjorn
    Soderberg, Stefan
    Rolandsson, Olov
    DIABETES, 2020, 69
  • [23] DIABETES IN CHRONIC-ALCOHOLIC PANCREATITIS - ROLE OF RESIDUAL BETA-CELL FUNCTION AND INSULIN RESISTANCE
    CAVALLINI, G
    VAONA, B
    BOVO, P
    CIGOLINI, M
    RIGO, L
    ROSSI, F
    TASINI, E
    BRUNORI, MP
    DIFRANCESCO, V
    FRULLONI, L
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (03) : 497 - 501
  • [24] Family History of Type 2 Diabetes and Its Association with Beta Cell Function and Lipid Profile in Newly Diagnosed Pediatric Patients with Type 1 Diabetes
    Chi, Dan
    Zhu, Mingqiang
    Dong, Guanping
    Gao, Hui
    Xiang, Wenqing
    Ye, Qing
    Fu, Junfen
    ENDOCRINE RESEARCH, 2024, 49 (03) : 117 - 123
  • [25] The effects of insulin and OHA therapy on beta cell function in newly diagnosed type 2 diabetes mellitus
    Yan, Z.
    Li, Y.
    DIABETOLOGIA, 2006, 49 : 605 - 605
  • [26] Effect of Basal Insulin Plus Oral Antidiabetes Drug Therapy on beta-Cell Function and Glycaemic Control in Patients with Newly Diagnosed Type 2 Diabetes
    Mu, Pan-Wei
    Zeng, Long-Yi
    Chen, Yan-Ming
    Lu, Hong-Yun
    Wen, Xing-Qiao
    Zhang, Guo-Chao
    Xie, Ru-Ying
    Wang, Man-Man
    Shu, Jiong
    DIABETES, 2011, 60 : A288 - A288
  • [27] Intensive Glucose Lowering Therapy Maintains Beta-Cell Function for 6 Years in Newly Diagnosed Type 2 Diabetes
    Harrison, Lindsay B.
    Raskin, Philip
    Adams-Huet, Beverley
    Li, Xilong
    Lingvay, Ildiko
    DIABETES, 2013, 62 : A244 - A244
  • [28] Reversibility of β-cell function and insulin resistance in newly diagnosed type 2 diabetes.: An implication for the pathogenesis
    Takami, K
    Takeda, N
    Koseki, O
    Kawachi, S
    Sasaki, A
    Takami, R
    Yoshino, K
    Hattori, J
    Hayashi, M
    DIABETES, 1999, 48 : A28 - A28
  • [29] INSULIN RESISTANCE AND BETA-CELL FUNCTION IN WERNER SYNDROME (ADULT PROGERIA)
    PUY, H
    DEBUSSCHE, X
    LAMORIL, J
    RUTO, F
    MARCELLI, JM
    QUICHAUD, J
    DESMET, G
    DIABETES NUTRITION & METABOLISM, 1993, 6 (02) : 103 - 106
  • [30] Differences in complication patterns in subgroups of type 2 diabetes according to insulin resistance and beta-cell function
    Cho, Yongin
    Ha Seo, Seong
    Seo, Da Hea
    Ahn, Seong Hee
    Hong, Seongbin
    Huh, Byung Wook
    Lee, Yong-ho
    Park, Seok Won
    Suh, Young Ju
    Kim, So Hun
    SCIENTIFIC REPORTS, 2022, 12 (01)